An Observational Longitudinal Prospective Long-Term Registry of Patients With Hypophosphatasia

Brief description of study

This multinational, multicenter, observational, prospective, long-term registry is designed to collect data on epidemiology, hypophosphatasia (HPP) history, clinical course, symptoms (including systemic aspects of disease), and burden of disease from patients of all ages who have a diagnosis of HPP. In addition, the Registry will collect data on asfotase alfa dosing, effectiveness of treatment, serious adverse events (SAEs), antidrug antibodies (ADAs) against asfotase alfa, pregnancy and neonatal outcome data (for patients treated with asfotase alfa only), and targeted events.

Clinical Study Identifier: s22-00229
Principal Investigator: Berrin Monteleone.
Other Investigator: Liana Gabriel.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.